Share information

Stem Cell Sciences has been listed on the Alternative Investment Market (AIM) in London since 2005 under the ticker symbol AIM: STEM.

View SCS on the AIM index of the London Stock Exchange

Stem Cell Sciences is also listed on the Australian Stock Exchange under the ticker symbol ASX: STC where securities are traded in the form of CHESS Depository Instruments.

View SCS on the ASX index of the Australian Stock Exchange

Shareholder Details

The Company’s issued share capital consists of 33,516,149 ordinary shares with a nominal value of 1.0 pence each (“Ordinary Shares”), each share having equal voting rights.

The Company does not hold any Ordinary Shares in treasury and therefore the total number of Ordinary Shares with voting rights is 33,516,149.

As of 1 May 2008 the Company had been notified, in accordance with the Disclosure and Transparency Rules, of the following shareholdings amounting to 3% or more of the ordinary share capital of the Company:
Shareholder	Number of ordinary shares	% of issued share capital
HSBC Global Custody Nominee (UK)	3,280,000	9.79
Secure Sciences pty Limited	2,668,633	7.96
Biotech Capital Limited	2,400,000	7.16
J P Morgan Nominees Australia	1,800,000	5.37

In accordance with the AIM Rules (Rule 26), insofar as the Company is aware, the percentage of the Company's issued share capital that is not in public hands is 18.15%. This percentage comprises the holdings of Peter Mountford (through his interest in Secure Sciences pty Ltd and Mountford Family Trust), David Dodd, Mike Dexter and Les Webb, who are the only directors currently holding shares in the Company. Harry Karelis does not hold shares in his own name but is connected with Biotech Capital Ltd, of which he is a director.

Security Transfer Restrictions

The following securities in relation to Stem Cell Sciences plc have been classified by the ASX as restricted securities for a period of 24 months from 18 July 2005.
	Name of holder	Details of restricted securities
1.	Secure Sciences pty Ltd	3,300,000 ordinary fully paid shares
2.	Hugh Ilyine	360,256 options
3.	Leslie Harold Webb	62,400 options
4.	David Newton	62,400 options
5.	Harry Karelis	50,000 options
6.	Michael Dexter	400,000 options
7.	Mountford Family Trust	50,000 options